期刊文献+

PML—RARα阴性的急性早幼粒细胞白血病伴乳腺粒细胞肉瘤一例

原文传递
导出
摘要 患者女,25岁,2010年5月无明显诱因出现头晕、乏力。查体:中度贫血貌,皮肤黏膜未见瘀点瘀斑,浅表淋巴结不大,胸骨无压痛,心肺听诊未闻及明显异常,腹软,肝脾肋下未触及,双下肢无水肿。既往无慢性疾病史。
出处 《白血病.淋巴瘤》 CAS 2012年第6期382-383,共2页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献8

  • 1Byrd JC, Edenfield WJ, Shields, D J, et al. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a elinical review, J Clin Oncol, 1995, 13:1800-1816.
  • 2Vega-Ruiz A, Faderl S, Estrov Z, et al. Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single- institution experience. Int J Hematol, 2009, 89:489-496.
  • 3Au WY, Chan GC, Chim CS, et al. External auditory canal tumor: a rare chloroma in acute promyelocytic leukemia with a complete response to arsenic trioxide. J Clin Oncol, 2001, 19:3993-3995.
  • 4Disel V, Yavuz S, Paydas S, et al. Extramedullary relapse in thepleura in acute promyelocytic leukemia. Leuk Lymphoma, 2003, 44: 189-191.
  • 5Ko BS, Tang JL, Chen YC. et al. Extramedullmy relapse after all-trans retinoic acid for treatment acute promyelocytic leukemia-the occurrence of retinoic acid syndrome is a risk factor. Leukemia, 1999, 13:1406-1408.
  • 6黎承平,李淑娈,魏彩霞.PML—RARα融合基因监测急性早幼粒细胞白血病微小残留病[J].白血病.淋巴瘤,2009,18(5):281-283. 被引量:2
  • 7Redner RL. Variations on a theme: the alternate translocations in APL. Leukemia, 2002, 16:1927-1932.
  • 8de Th6 H, Chen Z. Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat Rev Cancer, 2010, 10:775-783.

二级参考文献7

  • 1Gonzalez M, Barragan E, Bolufer P, et al. Pretreatment characteristics and clinical outcome of acute promyelocytic leukemia patients according to the PMURARα isoforms:a study of the pethema group. Br J Haematol, 2001, 114: 99-103.
  • 2Fujita K, Oba R, Harada H, et al. Cytogenetics,FISH and RT-PCR analysis of acute promyelocytic leukemia:structure of the fusion point in a case lacking classic t (15;17) translocation. Leuk Lymphoma, 2003, 44:111-115.
  • 3Gupta V. Prognostic significance of PMIAIARα isoforms in adult patients with acute promyelocytic leukemia treated with all trails retinoic acid (ATRA) and chemotherapy. ASH, 2002, 11: (poster1266).
  • 4Jurcic JG, Nimer SD, Scheinberg DA, et al. Prognostic significance of minimal residual disease detection and PML/RARα isoform type: long-term follow-up in acute promyelocytic leukemia. Blood, 2001, 98: 2651-2656.
  • 5Santamaria C, Chillon MC, Fernandez C, et al. Using quantification of the PML-RARα transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia. Haematologica, 2007, 92:315-322.
  • 6Esteve J, Escoda L, Martin G, et al. Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with alltrans retinoic acid and anthracycline -based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention. Leukemia ,2007, 21: 446-452.
  • 7Sanz MA, Tallman MS, Lo-Coco F. Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Blood, 2005, 105: 3019-3025.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部